Whether LMA Protector is better than I Gel for airway management in obese patients undergoing laparoscopic cholecystectomy

Comparison of oropharyngeal leak pressure between supraglottic airway devices LMA Protector and I-Gel® in obese patients during laparoscopic cholecystectomy: A randomized control trial. - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/070136

Enrollment

Registered

2024-07-07

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: LMA Protector: Oropharyngeal leak pressure will be measured by closing the APL valve and opening fresh gas flow at 3l/min. Two readings of oropharyngeal leak pressure and peak pressure

Eligibility

Inclusion criteria

Inclusion criteria: 1. Obese patients 2. Age 18 to 60 years 3. ASA Physical status I and II planned for elective laparoscopic cholecystectomy

Exclusion criteria

Exclusion criteria: 1. Patient refusal 2. Anticipated difficult airway 3. History of gastroesophageal reflux diseases Patients with previous abdominal surgery and/or comorbidities that would affect surgical time time under anaesthesia 4. Expected duration of surgery is more than 3 hours 5. Any surgery with expected postoperative ICU admission

Design outcomes

Primary

Measure	Time frame
Oropharyngeal leak pressureTimepoint: 1. Before pneumoperitoneum 2. 15 minutes after pneumoperitoneum	—

Secondary

Measure	Time frame
To evaluate and compare The peak pressure before and after pneumoperitoneum Fiberoptic glottic views Insertion attempts Insertion time Number and type of airway manipulation Perioperative and postoperative anaesthesia-related problems Timepoint: Intra operative	—

Countries

India

Contacts

Public ContactDr Abhyuday Kumar

AIIMS Patna

drabhyudaykumar@aiimspatna.org9013512403

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026